SG11201508125XA - Protein kinase inhibitors - Google Patents

Protein kinase inhibitors

Info

Publication number
SG11201508125XA
SG11201508125XA SG11201508125XA SG11201508125XA SG11201508125XA SG 11201508125X A SG11201508125X A SG 11201508125XA SG 11201508125X A SG11201508125X A SG 11201508125XA SG 11201508125X A SG11201508125X A SG 11201508125XA SG 11201508125X A SG11201508125X A SG 11201508125XA
Authority
SG
Singapore
Prior art keywords
protein kinase
kinase inhibitors
inhibitors
protein
kinase
Prior art date
Application number
SG11201508125XA
Other languages
English (en)
Inventor
Srinivasan Rajagopalan
Prasad Appukuttan
Arumugam Karthikeyan Narasingapuram
Ravi Kotrabasaiah Ujjinamatada
Shyla George
Tero Linnanen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of SG11201508125XA publication Critical patent/SG11201508125XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
SG11201508125XA 2013-04-04 2014-04-03 Protein kinase inhibitors SG11201508125XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN382KO2013 2013-04-04
PCT/FI2014/000003 WO2014162039A1 (en) 2013-04-04 2014-04-03 Protein kinase inhibitors

Publications (1)

Publication Number Publication Date
SG11201508125XA true SG11201508125XA (en) 2015-10-29

Family

ID=50685938

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201508125XA SG11201508125XA (en) 2013-04-04 2014-04-03 Protein kinase inhibitors

Country Status (34)

Country Link
US (1) US20160031855A1 (zh)
EP (1) EP2981533B1 (zh)
JP (1) JP6356782B2 (zh)
KR (1) KR20150138383A (zh)
CN (1) CN105073733B (zh)
AR (1) AR095781A1 (zh)
AU (1) AU2014246961B2 (zh)
BR (1) BR112015025413A2 (zh)
CA (1) CA2907855A1 (zh)
CL (1) CL2015002932A1 (zh)
CY (1) CY1120306T1 (zh)
DK (1) DK2981533T3 (zh)
EA (1) EA031076B1 (zh)
ES (1) ES2658183T3 (zh)
HK (1) HK1217198A1 (zh)
HR (1) HRP20180382T1 (zh)
HU (1) HUE036692T2 (zh)
LT (1) LT2981533T (zh)
MA (1) MA38454B1 (zh)
MX (1) MX2015013776A (zh)
MY (1) MY184528A (zh)
NO (1) NO2981533T3 (zh)
NZ (1) NZ713410A (zh)
PE (1) PE20160115A1 (zh)
PH (1) PH12015502284B1 (zh)
PL (1) PL2981533T3 (zh)
PT (1) PT2981533T (zh)
RS (1) RS56942B1 (zh)
SA (1) SA515361260B1 (zh)
SG (1) SG11201508125XA (zh)
SI (1) SI2981533T1 (zh)
TW (1) TWI628176B (zh)
UA (1) UA115176C2 (zh)
WO (1) WO2014162039A1 (zh)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8754114B2 (en) 2010-12-22 2014-06-17 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
IL289834B1 (en) 2012-06-13 2024-03-01 Incyte Holdings Corp Conversion of tricyclic compounds as FGFR inhibitors
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
AR094812A1 (es) 2013-02-20 2015-08-26 Eisai R&D Man Co Ltd Derivado de piridina monocíclico como inhibidor del fgfr
SI2986610T1 (en) 2013-04-19 2018-04-30 Incyte Holdings Corporation Bicyclic heterocycles as inhibitors of FGFR
CA2956270C (en) 2014-08-18 2022-08-09 Eisai R&D Management Co., Ltd. Salt of monocyclic pyridine derivative and crystal thereof
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
ES2751669T3 (es) 2015-02-20 2020-04-01 Incyte Corp Heterociclos bicíclicos como inhibidores FGFR
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US10487863B2 (en) * 2017-02-17 2019-11-26 Ford Global Technologies, Llc Castellated joint for improved adhesive coverage when using mechanical fixings and adhesive in one joint
WO2018166493A1 (zh) 2017-03-16 2018-09-20 江苏恒瑞医药股份有限公司 杂芳基并[4,3-c]嘧啶-5-胺类衍生物、其制备方法及其在医药上的应用
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
CN111712245A (zh) 2018-03-28 2020-09-25 卫材R&D管理有限公司 用于肝细胞癌的治疗剂
EP3788047A2 (en) 2018-05-04 2021-03-10 Incyte Corporation Solid forms of an fgfr inhibitor and processes for preparing the same
MX2020011639A (es) 2018-05-04 2021-02-15 Incyte Corp Sales de un inhibidor de receptores de factor de crecimiento de fibroblastos (fgfr).
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
CA3129665A1 (en) 2019-03-21 2020-09-24 Onxeo A dbait molecule in combination with kinase inhibitor for the treatment of cancer
AU2020292664B2 (en) * 2019-06-14 2023-04-13 Cgenetech (Suzhou, China) Co., Ltd. Fused ring compound as FGFR and VEGFR dual inhibitor
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
CA3145680C (en) * 2019-07-26 2024-03-12 Zhengxia CHEN Pyridine derivative as fgfr and vegfr dual inhibitors
BR112022007163A2 (pt) 2019-10-14 2022-08-23 Incyte Corp Heterociclos bicíclicos como inibidores de fgfr
WO2021076728A1 (en) 2019-10-16 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
EP4054579A1 (en) 2019-11-08 2022-09-14 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
US11897891B2 (en) 2019-12-04 2024-02-13 Incyte Corporation Tricyclic heterocycles as FGFR inhibitors
KR20220131900A (ko) 2019-12-04 2022-09-29 인사이트 코포레이션 Fgfr 억제제의 유도체
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
WO2022203399A1 (ko) * 2021-03-26 2022-09-29 주식회사 스탠다임 아데노신 a2a 수용체 길항제 및 이의 용도
EP4352059A1 (en) 2021-06-09 2024-04-17 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1206260A4 (en) * 1999-06-30 2002-10-30 Merck & Co Inc SRC-KINASE INHIBITING COMPOUNDS
EP1194152A4 (en) * 1999-06-30 2002-11-06 Merck & Co Inc SIN KINASE INHIBITOR COMPOUNDS
MXPA06002018A (es) * 2003-08-21 2006-05-31 Osi Pharm Inc Bencimidazolilo n-sustituidos inhibidores de c-kit.
AU2007312310A1 (en) * 2006-10-16 2008-04-24 Novartis Ag Phenylacetamides useful as protein kinase inhibitors
JP5442448B2 (ja) * 2006-12-22 2014-03-12 アステックス、セラピューティックス、リミテッド Fgfrインヒビターとしての二環式ヘテロ環式化合物
EP2121687B1 (en) * 2006-12-22 2015-10-14 Astex Therapeutics Limited Tricyclic amine derivatives as protein tyrosine kinase inhibitors
GB0906472D0 (en) * 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
WO2011038579A1 (en) * 2009-09-30 2011-04-07 Zhejiang Beta Pharma Inc. Compounds and compositions as protein kinase inhibitors
UA111382C2 (uk) * 2011-10-10 2016-04-25 Оріон Корпорейшн Інгібітори протеїнкінази

Also Published As

Publication number Publication date
WO2014162039A1 (en) 2014-10-09
SI2981533T1 (en) 2018-04-30
MA38454A1 (fr) 2018-02-28
JP6356782B2 (ja) 2018-07-11
TWI628176B (zh) 2018-07-01
PE20160115A1 (es) 2016-03-03
UA115176C2 (uk) 2017-09-25
AU2014246961A1 (en) 2015-10-22
MA38454B1 (fr) 2018-11-30
AR095781A1 (es) 2015-11-11
PH12015502284A1 (en) 2016-02-01
EP2981533B1 (en) 2017-12-06
PL2981533T3 (pl) 2018-04-30
EA031076B1 (ru) 2018-11-30
KR20150138383A (ko) 2015-12-09
SA515361260B1 (ar) 2017-08-27
MX2015013776A (es) 2016-02-26
NZ713410A (en) 2018-07-27
CA2907855A1 (en) 2014-10-09
JP2016515604A (ja) 2016-05-30
NO2981533T3 (zh) 2018-05-05
RS56942B1 (sr) 2018-05-31
LT2981533T (lt) 2018-02-26
EA201591913A1 (ru) 2016-03-31
TW201524970A (zh) 2015-07-01
AU2014246961B2 (en) 2017-09-28
EP2981533A1 (en) 2016-02-10
US20160031855A1 (en) 2016-02-04
ES2658183T3 (es) 2018-03-08
MY184528A (en) 2021-04-01
CN105073733A (zh) 2015-11-18
BR112015025413A2 (pt) 2017-07-18
HUE036692T2 (hu) 2018-07-30
PT2981533T (pt) 2018-02-27
PH12015502284B1 (en) 2016-02-01
HK1217198A1 (zh) 2016-12-30
HRP20180382T1 (hr) 2018-04-06
CL2015002932A1 (es) 2016-04-22
CN105073733B (zh) 2017-06-27
DK2981533T3 (en) 2018-02-12
CY1120306T1 (el) 2019-07-10

Similar Documents

Publication Publication Date Title
HK1217198A1 (zh) 蛋白激酶抑制劑
IL256946B (en) Bromodomain inhibitors
HK1224296A1 (zh) 布羅莫結構域抑制劑
HK1220459A1 (zh) 激酶抑制劑
HK1215577A1 (zh) 蛋白激酶抑制劑
IL241123A0 (en) Dihydro-pyrrolopyridinones as inhibitors of bromo sites
HK1218119A1 (zh) 蛋白激酶抑制劑
HK1211578A1 (zh) 作為 激酶抑制劑的酰氨基咪唑並噠嗪
HK1214813A1 (zh) 激酶抑制劑
HK1210774A1 (zh) 取代的 -氨基吡啶類蛋白激酶抑制劑
HK1219104A1 (zh) 激酶抑制劑
HK1209726A1 (zh) 蛋白激酶抑制劑
HK1205506A1 (zh) 炔類化合物的蛋白激酶抑制劑
EP3007689A4 (en) NON-SELECTIVE KINASE INHIBITORS
HK1208460A1 (zh) 蛋白激酶抑制劑
EP2968358A4 (en) NOVEL CHOLINKINASE INHIBITORS
IL244029A0 (en) Deoxycytodine kinase inhibitors
EP3071572A4 (en) Protein kinase inhibitors
EP3074401A4 (en) Protein kinase inhibitors
EP3071573A4 (en) Protein kinase inhibitors
GB201307155D0 (en) Kinase inhibitors